Translational Biosciences   Report issue

For profit Phase 2
Founded: Panama City Panama (2014)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2014
NCT01885819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Translational Biosciences / Stem Cell Institute Panama

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Asthma (Phase 2)

Autistic Disorder (Phase 2)

Multiple Sclerosis (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Sclerosis (Phase 2)

Spinal Cord Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 4